PAI-1, progress in understanding the clinical problem and its aetiology

Intra-airway administration of small interfering RNA targeting plasminogen activator inhibitor-1 attenuates allergic asthma in mice

(2011) Shintaro Miyamoto et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Association of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma

(2011) Seong Cho et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Life-threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor-1 deficiency in humans

(2011) T. IWAKI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Rare inherited disorders of fibrinogen

(2010) S. S. ACHARYA et al.   HAEMOPHILIA

Plasminogen activator inhibitor type 1 deficiency

(2010) R. MEHTA et al.   HAEMOPHILIA

Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor

(2010) Anne Masset et al.   INTERNATIONAL JOURNAL OF CANCER

Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture

(2009) Z. Xu et al.   BLOOD

Plasminogen Activator Inhibitor-1 Protects Endothelial Cells from FasL-Mediated Apoptosis

(2008) Khalid Bajou et al.   CANCER CELL

The Hemostasis System in Murine Atherosclerosis

(2008) Francis Castellino et al.   CURRENT DRUG TARGETS

Fibrinolysis: The Key to New Pathogenetic Mechanisms

(2008) Esther Zorio et al.   CURRENT MEDICINAL CHEMISTRY